INTELLIGENT BIO SOLUTIONS INC. Deferred Income, Current
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Deferred Income, Current of $2.28 million as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredIncomeCurrent · last filed 2025-08-15
- 2025-03-31: Deferred Income, Current $2.28M.
- 2024-12-31: Deferred Income, Current $2.30M.
- 2024-09-30: Deferred Income, Current $2.59M.
- 2024-06-30: Deferred Income, Current $2.49M.
| Period end | Deferred Income, Current |
|---|---|
| 2025-03-31 | $2.28M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.30M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $2.59M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.49M 10-K · filed 2025-08-15 |
| 2024-03-31 | $2.29M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.43M 10-Q · filed 2024-02-09 |
| 2023-09-30 | $2.24M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.34M 10-K · filed 2024-09-18 |
| 2023-03-31 | $1.09M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.15M 10-Q · filed 2023-02-14 |
| 2022-06-30 | $2.84M 10-K · filed 2023-08-23 |
| 2022-03-31 | $3.38M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $3.42M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $1.83M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.10M 10-K · filed 2022-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |